 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Share Allotment Committee of Sandu Pharmaceuticals Limited met today on Thursday, 14th July 2022 at 2.30 pm and Meeting concluded at conclude at 3.35 pm, and considered and approved the conversion of the 03rd tranche of warrants into Equity Shares at a price of Rs.20.69 per share (Face Value Rs.10/- and Premium Rs.10.69 per share) in accordance with the terms of issue of warrants. Accordingly 8,50,326 equity shares has been allotted to the following persons / Companies upon conversion of the warrants held by them.
Shares of SANDU PHARMACEUTICALS LTD. was last trading in BSE at Rs. 67.00 as compared to the previous close of Rs. 66.50. The total number of shares traded during the day was 851 in over 15 trades.
The stock hit an intraday high of Rs. 68.50 and intraday low of 65.75. The net turnover during the day was Rs. 56514.00.